Factors predicting persistent thrombocytopenia after living donor liver transplantation in pediatric patients

Masaki Honda1, Hidekazu Yamamoto, Shintaro Hayashida

  • 1Department of Transplantation and Pediatric Surgery, Kumamoto University, Kumamoto, Japan.

Insights

Pediatric liver transplant patients frequently develop thrombocytopenia. Preoperative platelet count, graft-to-recipient weight ratio, and acute rejection are key predictors of this condition post-transplant.

Area of Science:

  • Pediatric Hepatology
  • Transplantation Immunology
  • Hematology

Background:

  • Thrombocytopenia is a frequent complication following liver transplantation (LT) in pediatric patients with end-stage liver disease.
  • Understanding the incidence and predictors of post-transplant thrombocytopenia (PLT) is crucial for optimizing patient outcomes.

Purpose of the Study:

  • To evaluate the incidence of thrombocytopenia in pediatric patients after living donor liver transplantation (LDLT).
  • To identify predictive factors associated with post-transplant thrombocytopenia (PLT <100,000/mm³).

Main Methods:

  • Retrospective analysis of 76 pediatric patients (≤15 years) who underwent LDLT.
  • Evaluation of platelet counts at two weeks and 12 months post-transplant.
  • Univariate and multivariate analyses to determine associations with thrombocytopenia.

Main Results:

  • Prevalence of thrombocytopenia was 28.9% at two weeks and 17.7% at 12 months post-LDLT.
  • Early thrombocytopenia was associated with age at transplant, preoperative platelet count, graft-to-recipient weight ratio (GRWR), acute rejection, and CMV infection.
  • Preoperative platelet count, GRWR, and acute rejection were significant predictors in multivariate analysis; preoperative platelet count was the sole predictor at 12 months.

Conclusions:

  • Preoperative platelet count, GRWR, and acute rejection are significant factors influencing thrombocytopenia after pediatric LDLT.
  • Post-operative monitoring of platelets aids in early detection of adverse events related to the liver graft.
  • Successful treatment of vascular complications led to platelet count recovery.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...